Lv1
70 积分 2025-11-14 加入
Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma
3天前
已完结
Clinical trials for patients with salivary gland cancers: A systematic review of worldwide registers and an evaluation of current challenges
4天前
已完结
Impact of tyrosine kinase inhibitors on disease control, survival, and safety in adenoid cystic carcinoma: A systematic review and meta-analysis
4天前
已完结
Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma
4天前
已完结
Cancer burden and control in China: landscape, trends and challenges
6天前
已完结
Survival Outcome of Salivary Gland Carcinoma: A 50-Year Retrospective Study With Long-Term Follow-up
9天前
已完结
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
1个月前
已完结
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
3个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
3个月前
已完结
皖公网安备34019202002308
